A clinical therapeutic protein drug–drug interaction study: coadministration of denosumab and midazolam in postmenopausal women with osteoporosis

Drug–disease interactions involving therapeutic proteins that target cytokines and potentially impact cytochrome P450 (CYP) enzymes have been of increased interest to drug regulatory agencies and industry sponsors in recent years. This parallel-group open-label study evaluated the effects of the mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Graham, Kaufman, Allegra, Lee, Edward, Hamilton, Lisa, Hutton, Shauna, Egbuna, Ogo, Padhi, Desmond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184705/
https://www.ncbi.nlm.nih.gov/pubmed/25505582
http://dx.doi.org/10.1002/prp2.33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184705/
https://www.ncbi.nlm.nih.gov/pubmed/25505582
http://dx.doi.org/10.1002/prp2.33

Ejemplares similares